[ad_1]
Pfizer / Biontech will supply Switzerland with three million doses of coronavirus vaccines, provided that Swissmedic has approved it. Following the declaration of intent, the federal government signed the corresponding contract, the BAG announced on Monday.
The Federal Office of Public Health (BAG) writes that two doses of the vaccine would likely be required. This would allow 1.5 million people to be vaccinated in Switzerland.
So far, Switzerland has signed contracts with three vaccine manufacturers whose products are well advanced in clinical development. In addition to Pfizer / Biontech, these are the vaccine manufacturers Moderna (about 4.5 million doses of vaccine) and Astrazeneca (about 5.3 million doses of vaccine). All three vaccine manufacturers are currently in the approval process at Swissmedic.
In addition, Switzerland is a member of the Covax initiative in order to gain access to vaccines for up to 20 percent of the Swiss population.
The federal government is still in talks with several vaccine manufacturers, according to BAG’s announcement Monday. Since it is not yet clear at this time which vaccines would prevail, the federal government is targeting several vaccines.
